Roche Holding AG (OTCMKTS:RHHVF) Given Average Recommendation of “Hold” by Analysts

Shares of Roche Holding AG (OTCMKTS:RHHVF) have received a consensus rating of “Hold” from the nine ratings firms that are covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and four have issued a buy rating on the company.

RHHVF has been the topic of several recent analyst reports. Sanford C. Bernstein restated a “buy” rating on shares of Roche in a research note on Wednesday, April 21st. JPMorgan Chase & Co. restated a “hold” rating on shares of Roche in a research note on Monday, July 5th. Barclays restated a “buy” rating on shares of Roche in a research note on Wednesday, April 21st. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Roche in a research note on Friday, June 25th.

OTCMKTS:RHHVF traded up $2.66 during trading hours on Friday, hitting $386.50. 1,825 shares of the company traded hands, compared to its average volume of 6,171. The business’s 50-day simple moving average is $365.49. Roche has a one year low of $308.57 and a one year high of $390.01.

Roche Company Profile

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation.

Recommended Story: Environmental, Social, and Governance (ESG) Investing

Analyst Recommendations for Roche (OTCMKTS:RHHVF)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.